Kevin Tang
10% owner, Boundless Bio, Inc.; 10% owner, Fulcrum Therapeutics, Inc.; Chief Executive Officer, Director, 10% owner, Aurinia Pharmaceuticals Inc.
Bought, 12 months
$27.7M
Sold, 12 months
$0.0M
Companies
3
Latest trade
Oct 26, 2026
Companies
Boundless Bio, Inc.10% owner +$1.9M Fulcrum Therapeutics, Inc.10% owner +$0.6M Aurinia Pharmaceuticals Inc.Chief Executive Officer, Director, 10% owner +$25.1MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.


